These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8519001)

  • 1. Clinical aspects of nimodipine.
    Grobe-Einsler R
    Clin Neuropharmacol; 1993; 16 Suppl 1():S39-45. PubMed ID: 8519001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.
    Pantoni L; Bianchi C; Beneke M; Inzitari D; Wallin A; Erkinjuntti T
    J Neurol Sci; 2000 Apr; 175(2):116-23. PubMed ID: 10831772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nimodipine in the treatment of old age dementias.
    Ban TA; Morey L; Aguglia E; Azzarelli O; Balsano F; Marigliano V; Caglieris N; Sterlicchio M; Capurso A; Tomasi NA
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(4):525-51. PubMed ID: 2236581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE).
    Wang P; Wang Y; Feng T; Zhao X; Zhou Y; Wang Y; Shi W; Ju Y;
    BMC Neurol; 2012 Sep; 12():88. PubMed ID: 22950711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent neuroprotective effects of nimodipine in PDD and MID provide indirect evidence of disturbances in Ca2+ homeostasis in dementia.
    Fischhof PK
    Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):549-55. PubMed ID: 7794292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebo-controlled trial.
    Pantoni L; del Ser T; Soglian AG; Amigoni S; Spadari G; Binelli D; Inzitari D
    Stroke; 2005 Mar; 36(3):619-24. PubMed ID: 15692125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mental deterioration in old age: results of two multicenter, clinical trials with nimodipine. The Nimodipine Study Group.
    Parnetti L; Senin U; Carosi M; Baasch H
    Clin Ther; 1993; 15(2):394-406. PubMed ID: 8519047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial.
    Pantoni L; Rossi R; Inzitari D; Bianchi C; Beneke M; Erkinjuntti T; Wallin A
    J Neurol Sci; 2000 Apr; 175(2):124-34. PubMed ID: 10831773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nimodipine fails to enhance the analgesic effect of slow release morphine in the early phases of cancer pain treatment.
    Roca G; Aguilar JL; Gomar C; Mazo V; Costa J; Vidal F
    Pain; 1996 Dec; 68(2-3):239-43. PubMed ID: 9121810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial.
    Petruk KC; West M; Mohr G; Weir BK; Benoit BG; Gentili F; Disney LB; Khan MI; Grace M; Holness RO
    J Neurosurg; 1988 Apr; 68(4):505-17. PubMed ID: 3280746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial.
    Salvadori E; Poggesi A; Donnini I; Rinnoci V; Chiti G; Squitieri M; Tudisco L; Fierini F; Melone A; Pescini F; Pantoni L
    Drugs Aging; 2021 Jun; 38(6):481-491. PubMed ID: 33855653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind study of nimodipine in non-severe stroke.
    Bogousslavsky J; Regli F; Zumstein V; Köbberling W
    Eur Neurol; 1990; 30(1):23-6. PubMed ID: 2404768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms.
    Jan M; Buchheit F; Tremoulet M
    Neurosurgery; 1988 Aug; 23(2):154-7. PubMed ID: 3054619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is nimodipine useful in migraine prophylaxis? Further considerations.
    Leone M; Frediani F; Patruno G; Valentini S; Bussone G
    Headache; 1990 May; 30(6):363-5. PubMed ID: 2196239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical findings with nimodipine in dementia: test of the calcium hypothesis.
    Fritze J; Walden J
    J Neural Transm Suppl; 1995; 46():439-53. PubMed ID: 8821080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and clinical relevance of cognition enhancers.
    Herrmann WM; Stephan K
    Alzheimer Dis Assoc Disord; 1991; 5 Suppl 1():S7-12. PubMed ID: 1781976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nimodipine in acute ischemic stroke: a double-blind controlled study.
    Paci A; Ottaviano P; Trenta A; Iannone G; De Santis L; Lancia G; Moschini E; Carosi M; Amigoni S; Caresia L
    Acta Neurol Scand; 1989 Oct; 80(4):282-6. PubMed ID: 2683557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very Early Nimodipine Use in Stroke (VENUS): a randomized, double-blind, placebo-controlled trial.
    Horn J; de Haan RJ; Vermeulen M; Limburg M
    Stroke; 2001 Feb; 32(2):461-5. PubMed ID: 11157183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global rating, symptoms, behavior, and cognitive performance as indicators of efficacy in clinical studies with nimodipine in elderly patients with cognitive impairment syndromes.
    Schmage N; Bergener M
    Int Psychogeriatr; 1992; 4 Suppl 1():89-99. PubMed ID: 1504290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Brain aging and calcium antagonist drugs. A preliminary open study with nimodipine].
    Centonze V; Massaro C; Polito BM; Cassiano MA; Di Bari M; Russo P; Cirillo L; Albano O
    Clin Ter; 1992 Jan; 140(1):11-5. PubMed ID: 1526092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.